Compare PRU & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRU | KVUE |
|---|---|---|
| Founded | 1875 | 2022 |
| Country | United States | United States |
| Employees | 36824 | N/A |
| Industry | Life Insurance | Specialty Chemicals |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.6B | 32.9B |
| IPO Year | N/A | 2023 |
| Metric | PRU | KVUE |
|---|---|---|
| Price | $119.91 | $19.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 11 |
| Target Price | ★ $103.71 | $19.45 |
| AVG Volume (30 Days) | 1.4M | ★ 16.6M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.81% | 4.82% |
| EPS Growth | N/A | ★ 40.74 |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $15,124,000,000.00 |
| Revenue This Year | N/A | $4.85 |
| Revenue Next Year | $3.06 | $2.63 |
| P/E Ratio | ★ $10.44 | $77.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $91.89 | $14.02 |
| 52 Week High | $120.59 | $22.44 |
| Indicator | PRU | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 68.10 | 55.97 |
| Support Level | $99.97 | $16.83 |
| Resistance Level | N/A | $20.13 |
| Average True Range (ATR) | 2.16 | 0.39 |
| MACD | 0.06 | -0.07 |
| Stochastic Oscillator | 86.92 | 40.32 |
Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2025 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 39% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 11% of its 2025 adjusted earnings. PGIM had around $1.47 trillion in assets under management at the end of fourth-quarter 2025.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.